PATRICK DEVAL L — SEC insider filings
SEC reporting owner CIK 1053466. 54 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers the 50 most recent of 54 filings on record, filed 2021-06-17 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 12,667 shares, $264,680 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 118,890 shares, $3,460,810 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 73.
- Largest priced transaction: sale of 47,705 shares @ $30.78 ($1,468,422) in Cerevel Therapeutics Holdings, Inc., filed 2022-09-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings, Inc. (CERE) | Director | 6 | — | 2 legs · 77,835 sh · $2,221,672 | 11 |
| Toast, Inc. (TOST) | Director | 14 | 1 leg · 1,667 sh · $66,680 | 2 legs · 35,889 sh · $1,191,119 | 23 |
| American Well Corp (AMWL) | Director | 5 | 2 legs · 11,000 sh · $198,000 | 1 leg · 5,166 sh · $48,020 | 3 |
| TWILIO INC (TWLO) | Director | 21 | — | — | 21 |
| Global Blood Therapeutics, Inc. (GBT) | Director | 3 | — | — | 14 |
| GreenLight Biosciences Holdings, PBC (GRNA) | — | 1 | — | — | 1 |
Insider filings — PATRICK DEVAL L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 337 @ $0 | EDGAR |
| 2026-06-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 391 @ $0 | EDGAR |
| 2026-06-16 | 4 | Toast, Inc. (TOST) | Option exercise (M): 5,256 (derivative) @ $0 · Option exercise (M): 5,256 (derivative) @ $0 · Grant/award (A): 8,888 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Toast, Inc. (TOST) | Sale (S): 1,667 @ $36.95 | EDGAR |
| 2026-03-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 673 @ $0 | EDGAR |
| 2025-12-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 627 @ $0 | EDGAR |
| 2025-09-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 763 @ $0 | EDGAR |
| 2025-06-17 | 4 | Toast, Inc. (TOST) | Grant/award (A): 5,256 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | TWILIO INC (TWLO) | Grant/award (A): 691 @ $0 | EDGAR |
| 2025-06-10 | 4 | Toast, Inc. (TOST) | Option exercise (M): 9,712 (derivative) @ $0 · Option exercise (M): 9,712 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | TWILIO INC (TWLO) | Grant/award (A): 618 @ $0 | EDGAR |
| 2025-03-14 | 4 | Toast, Inc. (TOST) | Sale (S): 34,222 @ $33.01 | EDGAR |
| 2024-12-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 732 @ $0 | EDGAR |
| 2024-09-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,240 @ $0 | EDGAR |
| 2024-08-05 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Disposition to issuer (D): 3,282 · Disposition to issuer (D): 10,461 · Disposition to issuer (D): 49,794 (derivative) | EDGAR |
| 2024-06-10 | 4 | Toast, Inc. (TOST) | Option exercise (M): 11,593 @ $0 · Option exercise (M): 11,593 (derivative) @ $0 · Grant/award (A): 9,712 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 10,461 | EDGAR |
| 2024-06-07 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,234 @ $0 | EDGAR |
| 2024-03-19 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,195 @ $0 | EDGAR |
| 2024-02-26 | 4 | Toast, Inc. (TOST) | Option exercise (M): 7,645 · Option exercise (M): 7,645 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,153 @ $0 | EDGAR |
| 2023-11-03 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 30,130 @ $12.62 · Sale (S): 30,130 @ $25 · Option exercise (M): 30,130 (derivative) @ $0 | EDGAR |
| 2023-09-19 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,192 @ $0 | EDGAR |
| 2023-07-26 | 4 | GreenLight Biosciences Holdings, PBC (GRNA) | Other (J): 172,500 | EDGAR |
| 2023-06-26 | 4 | American Well Corp (AMWL) | Grant/award (A): 91,743 @ $0 | EDGAR |
| 2023-06-14 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,310 @ $0 | EDGAR |
| 2023-06-12 | 4 | Toast, Inc. (TOST) | Grant/award (A): 11,593 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 3,282 · Grant/award (A): 13,780 (derivative) @ $0 | EDGAR |
| 2023-06-05 | 4 | Toast, Inc. (TOST) | Option exercise (M): 11,292 @ $0 · Option exercise (M): 11,292 (derivative) @ $0 | EDGAR |
| 2023-03-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,101 @ $0 | EDGAR |
| 2023-02-24 | 4 | Toast, Inc. (TOST) | Option exercise (M): 7,640 · Option exercise (M): 7,640 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,565 @ $0 | EDGAR |
| 2022-10-06 | 4 | Global Blood Therapeutics, Inc. (GBT) | Disposition to issuer (D): 9,037 · Disposition to issuer (D): 3,600 (derivative) · Disposition to issuer (D): 625 (derivative) · Disposition to issuer (D): 5,247 (derivative) · Disposition to issuer (D): 5,600 (derivative) · Disposition to issuer (D): 5,600 (derivative) | EDGAR |
| 2022-09-19 | 4 | TWILIO INC (TWLO) | Grant/award (A): 1,008 @ $0 | EDGAR |
| 2022-09-14 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 47,705 @ $12.62 · Sale (S): 47,705 @ $30.78 · Option exercise (M): 47,705 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 736 @ $0 | EDGAR |
| 2022-06-16 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 23,459 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Global Blood Therapeutics, Inc. (GBT) | Option exercise (M): 3,600 · Option exercise (M): 3,600 (derivative) @ $0 · Grant/award (A): 5,600 (derivative) @ $0 · Grant/award (A): 3,600 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | American Well Corp (AMWL) | Grant/award (A): 50,377 @ $0 | EDGAR |
| 2022-06-03 | 4 | Toast, Inc. (TOST) | Grant/award (A): 11,292 (derivative) @ $0 | EDGAR |
| 2022-04-22 | 4 | American Well Corp (AMWL) | Purchase (P): 3,000 @ $18 · Purchase (P): 8,000 @ $18 | EDGAR |
| 2022-03-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 431 @ $0 | EDGAR |
| 2022-02-24 | 4 | Toast, Inc. (TOST) | Option exercise (M): 7,645 · Option exercise (M): 7,645 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 263 @ $0 | EDGAR |
| 2021-11-04 | 4 | American Well Corp (AMWL) | Sale (S): 5,166 @ $9.30 | EDGAR |
| 2021-10-29 | 4 | Toast, Inc. (TOST) | Other (J): 22,930 (derivative) @ $0 · Other (J): 22,930 (derivative) @ $0 | EDGAR |
| 2021-09-27 | 4 | Toast, Inc. (TOST) | Purchase (P): 1,667 @ $40 · Other (J): 22,930 (derivative) @ $0 · Other (J): 22,930 (derivative) @ $0 | EDGAR |
| 2021-09-17 | 4 | TWILIO INC (TWLO) | Grant/award (A): 210 @ $0 | EDGAR |
| 2021-06-21 | 4 | Global Blood Therapeutics, Inc. (GBT) | Option exercise (M): 3,037 · Option exercise (M): 3,037 (derivative) @ $0 · Grant/award (A): 5,600 (derivative) @ $0 · Grant/award (A): 3,600 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | American Well Corp (AMWL) | Grant/award (A): 14,440 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1053466 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs